Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience
A M Slats(Amsterdam UMC Location Vrije Universiteit Amsterdam), C. Michel Zwaan(Hôpital Saint-Michel), K. Hählen, Willem A. Kamps(Pediatric Oncology Group), A van der Does-van den Berg(Universität Hamburg), C Korbijn(Stichting Kinderoncologie Nederland), R. Maarten Egeler(Leiden University Medical Center)
Cited by 132
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599